| Authors: |
Sorouri K; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; University of Alberta, Edmonton, Alberta, Canada., Zheng Y; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Sella T; Sheba Medical Center, Ramat Gan, Israel., Rosenberg SM; Weill Cornell Medicine, New York, New York., Loucks M; UMass Memorial Medical Center, Worcester, Massachusetts., Kirkner GJ; Dana-Farber Cancer Institute, Boston, Massachusetts., Snow C; Dana-Farber Cancer Institute, Boston, Massachusetts., Ruddy KJ; Mayo Clinic, Rochester, Minnesota., Gelber SI; Dana-Farber Cancer Institute, Boston, Massachusetts., Tamimi RM; Weill Cornell Medicine, New York, New York., Peppercorn JM; Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts., Schapira L; Stanford Cancer Institute, Palo Alto, California., Borges VF; University of Colorado Comprehensive Cancer Center, Aurora, Colorado., Come SE; Harvard Medical School, Boston, Massachusetts; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Warner E; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Ginsburg ES; Brigham and Women's Hospital, Boston, Massachusetts., Partridge AH; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts. |